TipRanks
Par Drugs and Chemicals Limited (IN:PAR)
:PAR
India Market
Want to see IN:PAR full AI Analyst Report?

Par Drugs and Chemicals Limited (PAR) Ratios

1 Followers

Par Drugs and Chemicals Limited Ratios

IN:PAR's free cash flow for Q1 2027 was ₹0.48. For the 2027 fiscal year, IN:PAR's free cash flow was decreased by ₹ and operating cash flow was ₹0.17. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
0.00 4.68 3.31 4.79 3.53
Quick Ratio
0.00 4.29 2.94 4.44 3.11
Cash Ratio
0.00 3.04 1.66 2.95 1.59
Solvency Ratio
-0.16 0.98 0.83 1.12 0.83
Operating Cash Flow Ratio
0.00 1.20 0.98 1.63 0.96
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
₹ 1.12B₹ 470.98M₹ 344.46M₹ 436.44M₹ 318.07M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
0.00 1.15 1.21 1.19 1.25
Debt Service Coverage Ratio
141.95 133.07 181.93 167.48 110.36
Interest Coverage Ratio
145.70 105.48 195.18 515.02 109.29
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.09 0.10 0.07 0.09 0.11
Net Debt to EBITDA
0.00 -1.98 -1.41 -1.60 -1.21
Profitability Margins
Gross Profit Margin
50.75%48.69%61.19%63.77%30.17%
EBIT Margin
15.31%16.81%15.87%20.41%16.00%
EBITDA Margin
18.76%20.39%19.31%24.00%19.40%
Operating Profit Margin
14.87%12.95%15.87%57.67%15.31%
Pretax Profit Margin
17.59%16.69%17.75%20.41%15.86%
Net Profit Margin
13.31%12.65%13.23%15.16%11.92%
Continuous Operations Profit Margin
13.31%12.65%13.23%15.16%11.92%
Net Income Per EBT
75.67%75.77%74.53%74.30%75.16%
EBT Per EBIT
118.33%128.85%111.85%35.38%103.59%
Return on Assets (ROA)
0.00%10.15%11.19%14.27%12.75%
Return on Equity (ROE)
13.27%11.71%13.50%16.93%15.91%
Return on Capital Employed (ROCE)
0.00%11.63%15.58%61.86%19.44%
Return on Invested Capital (ROIC)
0.00%8.81%11.62%45.96%14.61%
Return on Tangible Assets
0.00%10.15%11.19%14.27%12.74%
Earnings Yield
9.30%13.55%12.53%5.32%6.58%
Efficiency Ratios
Receivables Turnover
0.00 8.54 6.01 6.93 5.58
Payables Turnover
0.00 6.49 3.60 6.47 8.21
Inventory Turnover
0.00 9.90 6.42 7.84 11.13
Fixed Asset Turnover
0.00 2.79 2.59 2.31 2.46
Asset Turnover
0.00 0.80 0.85 0.94 1.07
Working Capital Turnover Ratio
4.31 2.33 2.36 2.31 2.96
Cash Conversion Cycle
0.00 23.38 16.20 42.85 53.75
Days of Sales Outstanding
0.00 42.74 60.78 52.70 65.42
Days of Inventory Outstanding
0.00 36.87 56.87 46.57 32.80
Days of Payables Outstanding
0.00 56.23 101.44 56.42 44.48
Operating Cycle
0.00 79.62 117.65 99.27 98.23
Cash Flow Ratios
Operating Cash Flow Per Share
6.58 13.35 13.14 16.45 10.87
Free Cash Flow Per Share
5.99 11.76 12.14 11.51 4.67
CapEx Per Share
0.59 1.59 1.00 4.94 6.20
Free Cash Flow to Operating Cash Flow
0.91 0.88 0.92 0.70 0.43
Dividend Paid and CapEx Coverage Ratio
11.23 8.38 13.17 3.33 1.75
Capital Expenditure Coverage Ratio
11.23 8.38 13.17 3.33 1.75
Operating Cash Flow Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
0.07 0.16 0.16 0.21 0.14
Free Cash Flow Yield
4.73%14.96%14.01%5.20%3.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
10.75 7.38 7.98 18.79 15.20
Price-to-Sales (P/S) Ratio
1.43 0.93 1.06 2.85 1.81
Price-to-Book (P/B) Ratio
1.39 0.86 1.08 3.18 2.42
Price-to-Free Cash Flow (P/FCF) Ratio
21.13 6.68 7.14 19.23 29.99
Price-to-Operating Cash Flow Ratio
19.25 5.89 6.60 13.45 12.88
Price-to-Earnings Growth (PEG) Ratio
4.42 -3.82 -1.02 0.67 0.66
Price-to-Fair Value
1.39 0.86 1.08 3.18 2.42
Enterprise Value Multiple
7.63 2.60 4.05 10.27 8.13
Enterprise Value
1.56B 548.81M 790.39M 2.36B 1.50B
EV to EBITDA
7.63 2.60 4.05 10.27 8.13
EV to Sales
1.43 0.53 0.78 2.47 1.58
EV to Free Cash Flow
21.13 3.79 5.29 16.64 26.12
EV to Operating Cash Flow
19.25 3.34 4.89 11.64 11.21
Tangible Book Value Per Share
91.01 90.98 80.47 69.56 57.90
Shareholders’ Equity Per Share
91.01 90.98 80.47 69.56 57.90
Tax and Other Ratios
Effective Tax Rate
0.24 0.24 0.25 0.26 0.25
Revenue Per Share
88.49 84.21 82.09 77.69 77.28
Net Income Per Share
11.78 10.65 10.86 11.78 9.21
Tax Burden
0.76 0.76 0.75 0.74 0.75
Interest Burden
1.15 0.99 1.12 1.00 0.99
Research & Development to Revenue
0.00 0.00 <0.01 <0.01 <0.01
SG&A to Revenue
0.34 0.36 0.06 0.02 0.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.45 1.25 1.21 1.40 0.89
Currency in INR